• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Microbiol. Rapid semi-automated Subtyping of influenza during the 2009 swine-origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin.

Giuseppe

Emeritus
J Clin Microbiol. 2009 Jul 29. [Epub ahead of print]

Rapid semi-automated Subtyping of influenza during the 2009 swine-origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin.

Bose ME, Beck ET, Ledeboer N, Kehl SC, Jurgens LA, Patitucci T, Witt L, Lague E, Darga P, He J, Fan J, Kumar S, Henrickson KJ. - Midwest Respiratory Virus Program (MRVP), Department of Pediatrics and Pathology, Medical College of Wisconsin, Children's Research Institute, Children's Hospital of Wisconsin, Dynacare Laboratories, Milwaukee, Wisconsin, USA.


In spring of 2009 a novel influenza A (H1N1) virus [swine-origin influenza virus (S-OIV)] emerged and began causing a large outbreak in Milwaukee, WI. Our laboratory developed a semi-automated NucliSENS(R) easyMAG(TM) (bioM?rieux, Durham, NC) and Raider (Handylab Inc., Ann Arbor, MI)] real-time multiplex RT-PCR (Seasonal) assay that typed influenza A, influenza B, RSV and subtyped influenza A into currently circulating H1 and H3 subtypes and a similar assay that identified H1 of S-OIV. These assays demonstrated analytical limits of detection of <50 TCID50/ml and 3-30 input copies respectively. The analytical specificity demonstrated no cross-reactivity against 39, and 27 different common organisms tested and outstanding reproducibility. Clinical testing demonstrated 95% sensitivity against influenza A and influenza B and 95% and 97% specificity compared to tissue culture. Compared to other molecular tests positive agreement for the Seasonal and H1 S-OIV assays were 99% and 100% and negative agreement was 98% and 100%. This study has demonstrated the use of a semi-automated system for sensitive, specific, and rapid detection of influenza A, influenza B, and RSV and subtyping of influenza A into human H1 and H3 and S-OIV strains. This assay/system performed well in clinical testing of regular seasonal influenza subtypes and has been outstanding during the current Milwaukee S-OIV outbreak. This recent outbreak of a novel influenza A (H1N1) virus also demonstrates the importance of quickly distributing bioinformatics on new agents and in having rapid influenza subtyping assays widely available for clinical and public health decisions.

PMID: 19641066 [PubMed - as supplied by publishe
-
------
 
Back
Top